12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
12只醫療保健股票在週三盤前交易中有所波動
Gainers
贏家
- Mersana Therapeutics (NASDAQ:MRSN) shares rose 22.7% to $2.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $331.2 million. As per the news, the Q3 earnings report came out today.
- Kairos Pharma (AMEX:KAPA) stock rose 19.74% to $2.46. The market value of their outstanding shares is at $31.5 million.
- Calidi Biotherapeutics (AMEX:CLDI) shares increased by 18.48% to $2.5. The market value of their outstanding shares is at $29.1 million. The company's, Q3 earnings came out yesterday.
- Natera (NASDAQ:NTRA) shares rose 16.66% to $157.64. The company's market cap stands at $19.4 billion. As per the news, the Q3 earnings report came out yesterday.
- Ensysce Biosciences (NASDAQ:ENSC) stock increased by 15.62% to $0.78. The market value of their outstanding shares is at $11.6 million. The company's, Q3 earnings came out yesterday.
- Lexeo Therapeutics (NASDAQ:LXEO) stock increased by 12.61% to $8.66. The company's market cap stands at $286.3 million. The company's, Q3 earnings came out today.
- 在週三的盤前交易中,Mersana Therapeutics(納斯達克股票代碼:MRSN)股價上漲22.7%,至2.7美元。他們已發行股票的市值爲3.312億美元。根據新聞,第三季度收益報告今天發佈。
- Kairos Pharma(美國證券交易所股票代碼:KAPA)股價上漲19.74%,至2.46美元。他們已發行股票的市值爲3,150萬美元。
- Calidi Biotherapeutics(美國證券交易所股票代碼:CLDI)股價上漲18.48%,至2.5美元。他們已發行股票的市值爲2910萬美元。該公司昨天公佈了第三季度的收益。
- 納泰拉(納斯達克股票代碼:NTRA)股價上漲16.66%,至157.64美元。該公司的市值爲194億美元。根據新聞,第三季度收益報告於昨天發佈。
- Ensysce Biosciences(納斯達克股票代碼:ENSC)股價上漲15.62%,至0.78美元。他們已發行股票的市值爲1160萬美元。該公司昨天公佈了第三季度的收益。
- Lexeo Therapeutics(納斯達克股票代碼:LXEO)股價上漲12.61%,至8.66美元。該公司的市值爲2.863億美元。該公司今天公佈了第三季度的收益。
Losers
失敗者
- Syros Pharmaceuticals (NASDAQ:SYRS) shares decreased by 85.6% to $0.39 during Wednesday's pre-market session. The market value of their outstanding shares is at $10.5 million.
- GlucoTrack (NASDAQ:GCTK) stock decreased by 72.24% to $0.44. The market value of their outstanding shares is at $2.5 million.
- Psyence Biomedical (NASDAQ:PBM) stock fell 23.4% to $0.05. The company's market cap stands at $2.9 million.
- CERo Therapeutics Hldgs (NASDAQ:CERO) shares declined by 20.03% to $0.21. The market value of their outstanding shares is at $32.1 million.
- Geovax Labs (NASDAQ:GOVX) shares declined by 20.0% to $2.6. The company's market cap stands at $22.1 million. As per the press release, Q3 earnings came out yesterday.
- Virpax Pharmaceuticals (NASDAQ:VRPX) shares fell 17.6% to $0.51. The market value of their outstanding shares is at $2.4 million.
- 錫羅斯製藥公司(納斯達克股票代碼:SYRS)股價在週三的盤前交易中下跌了85.6%,至0.39美元。他們已發行股票的市值爲1,050萬美元。
- GlucoTrack(納斯達克股票代碼:GCTK)股價下跌72.24%,至0.44美元。他們已發行股票的市值爲250萬美元。
- Psyence Biomedical(納斯達克股票代碼:PBM)股票下跌23.4%,至0.05美元。該公司的市值爲290萬美元。
- CerO Therapeutics Hldgs(納斯達克股票代碼:CERO)股價下跌20.03%,至0.21美元。他們已發行股票的市值爲3,210萬美元。
- Geovax Labs(納斯達克股票代碼:GOVX)股價下跌20.0%,至2.6美元。該公司的市值爲2210萬美元。根據新聞稿,第三季度業績於昨天公佈。
- Virpax 製藥公司(納斯達克股票代碼:VRPX)股價下跌17.6%,至0.51美元。他們已發行股票的市值爲240萬美元。
This article was generated by Benzinga's automated content engine and reviewed by an editor.
本文由Benzinga的自動化內容引擎生成,並由編輯審閱。